Guardian Pharmacy Services, Inc.
GRDN
$23.24
-$0.87-3.61%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 338.57M | 314.39M | 287.72M | 287.72M | 281.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 338.57M | 314.39M | 287.72M | 287.72M | 281.07M |
| Cost of Revenue | 271.47M | 253.52M | 229.53M | 229.53M | 226.49M |
| Gross Profit | 67.10M | 60.88M | 58.19M | 58.19M | 54.58M |
| SG&A Expenses | 45.91M | 165.49M | 45.73M | 45.73M | 15.60M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 317.37M | 419.01M | 275.25M | 275.25M | 242.09M |
| Operating Income | 21.20M | -104.61M | 12.47M | 12.47M | 38.98M |
| Income Before Tax | 16.22M | -105.64M | 11.47M | 11.47M | 14.56M |
| Income Tax Expenses | 4.38M | 176.00K | 0.00 | -- | -- |
| Earnings from Continuing Operations | 11.84M | -105.82M | 11.47M | 11.47M | 14.56M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 102.00K | -6.82M | -4.77M | -4.77M | -2.54M |
| Net Income | 11.94M | -112.64M | 6.71M | 6.71M | 12.02M |
| EBIT | 21.20M | -104.61M | 12.47M | 12.47M | 38.98M |
| EBITDA | 26.35M | -99.62M | 17.28M | 17.28M | 43.69M |
| EPS Basic | 0.19 | -2.00 | -0.11 | -- | -- |
| Normalized Basic EPS | 0.21 | -1.19 | 0.04 | -- | -- |
| EPS Diluted | 0.19 | -2.00 | -0.11 | -- | -- |
| Normalized Diluted EPS | 0.21 | -1.19 | 0.04 | -- | -- |
| Average Basic Shares Outstanding | 62.04M | 61.14M | 61.14M | -- | -- |
| Average Diluted Shares Outstanding | 62.72M | 61.14M | 61.14M | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -10.93% | 177.05% | 177.05% | 83.21% |